ECHO-Antibiotic Stewardship Program

Similar documents
9/18/2018. Clostridium Difficile: Updates on Diagnosis and Treatment. Clostridium difficile Infection (CDI) Clostridium difficile Infection (CDI)

Clostridium Difficile colitismore

C. Difficile Testing Protocol

Loyola s C diff Journey

more intense treatments are needed to get rid of the infection.

Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review

Clostridium difficile

Journey to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer

Clostridium Difficile Infection in Adults Treatment and Prevention

Clostridium difficile Infection (CDI) Management Guideline

CLOSTRIDIUM DIFICILE. Negin N Blattman Infectious Diseases Phoenix VA Healthcare System

March 3, To: Hospitals, Long Term Care Facilities, and Local Health Departments

The incubation period is unknown. However; the onset of clinical disease is typically 5-10 days after initiation of antimicrobial treatment.

Clostridium difficile Essential information

Annex C: - CDI What s the diff? 4 th Annual Outbreak Management Workshop September 19, 2013 Naideen Bailey & Grace Volkening

A Pharmacist Perspective

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE

Surviving Norovirus. Not Just a Cruise Ship Issue. Maria Wellisch, RN, LFNA Vice President of Corporate Education Morningside Ministries

6/14/2012. Welcome! PRESENTATION OUTLINE CLOSTRIDIUM DIFFICILE PREVENTION. Teaming Up to Prevent Infections! 1) Impact. 2) Testing Recommendations

Stony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics

CONTROL OF VIRAL GASTROENTERITIS OUTBREAKS IN CALIFORNIA LONG-TERM CARE FACILITIES

C Difficile - The Ultimate Challenge: Controlling the Spread

Infection Prevention & Control Core Skills Level 2

Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose?

L. Clifford McDonald, MD. Senior Advisor for Science and Integrity September 16, 2015

Clostridium difficile: An Overview

Division of GIM Lecture Series Case Presentation David A. Erickson, M.D October 9th, 2013

DISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest wit

Lesson 1.5. The Usual Suspects. Estimated time: Two 50 min periods. Instructional overview. Instructional objectives. Assessment

Case 1. Which of the following would be next appropriate investigation/s regarding the pts diarrhoea?

Clostridium difficile Asymptomatic Carriers The Hidden Part of the Iceberg?

Hompes Method. Practitioner Training Level II. Lesson Seven Part A DRG Pathogen Plus Interpretation

Pros and Cons of Alternative Diagnostic Testing Strategies for C. difficile Infection

DUKE ANTIMICROBIAL STEWARDSHIP OUTREACH NETWORK (DASON) Antimicrobial Stewardship News. Volume 3, Number 6, June 2015

Conditional employee name (print) Food employee name (print) Address

Updates to pharmacological management in the prevention of recurrent Clostridium difficile

ABSTRACT PURPOSE METHODS

Hepatitis B and C Overview, Outbreaks, and Recommendations. Viral Hepatitis Language. Types of Viral Hepatitis 7/1/2013

C. difficile: The Changing Epidemiology Evaluations Clostridium difficile Thank You to our Sponsors

Clostridium difficile Infection: Diagnosis and Management

2018 CNISP HAI Surveillance Case definitions

Clostridium difficile infection surveillance: Applying the case definition

The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH

Injections Without Infections:

IP Lab Webinar 8/23/2012

Clostridium difficile

Fecal Microbiota Transplantation in C. diff. colitis Benefits and Limitations

JMSCR Vol 05 Issue 07 Page July 2017

Clostridium DifficileInfection & Readmissions: An ounce of prevention is worth a pound of cure

How to interpret the new QuantiFERON- TB Gold Plus test (QFT-Plus)

Hepatitis C January 26, 2018

By: Beth Calkins, RN, MSN

Questions and answers about the laboratory diagnosis of Clostridium difficile infection (CDI)

What s new in Infectious Diseases. Petronella Adomako, MD Infectious Disease Specialist Mckay-Dee Hospital

Stool bench. Cultures: SARAH

Infection control in Aged Residential Care Facilities. Dr Sally Roberts Clinical Advisor for IP&C Service, ADHB

Dr Alasdair Patrick Gastroenterologist

2/3/2011. Adhesion of Bifidobacterium lactis HN019 to human intestinal

GI Bacterial Infections (part-1)

All POOPed out: fecal microbiota transplant in C. difficile

Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection

EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE

Self-Instructional Packet (SIP)

EXPOSURE (HIV/HEPATITIS) BLOOD & BODY FLUIDS

New Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility

Clostridium difficile CRISTINA BAKER, MD, MPH INFECTIOUS DISEASE PARK NICOLLET/HEALTH PARTNERS 11/9/2018

Advances in Gastrointestinal Pathogen Detection

OCCUPATIONAL HEALTH DISEASE SPECIFIC RECOMMENDATIONS

How Pathogens Spread in the Healthcare Setting: Understanding the Basics. Objectives

Annex 7 Model Forms, Guides, and Other Aids

Los Angeles County Department of Public Health: Your Partner in CDI Prevention

Top 8 Pathogens. Print this document and study these pathogens. You will be better prepared to challenge the ADVANCED.fst exam.

Rapid-VIDITEST C. difficile Ag (GDH) Card/Blister

Biological Hazards Module 3

CURRENT INFECTIOUS DISEASE ISSUES. 11/2/15 Regina Won, MD

The Culture of Culturing: Laboratory Diagnostic Stewardship

Management of Outbreaks Care Homes IPC Study Day

Bloodborne Pathogens Training

Management of Clostridium Difficile: Total Colectomy versus Colon Sparing Surgery

HOSPITAL INFECTION CONTROL

-2002: Rectal blood loss, UC? (no definite diagnosis) rectal mesalazine. -June 2008: Recurrence of rectal blood loss and urgency

Understanding C. diff. atomalliance.org/cdifftraining

Outline. Cryptococcosis Pneumocystosis Diarrhea. Case Histories: HIV Related- Opportunistic Infections in 2015

Alberta Health and Wellness Public Health Notifiable Disease Management Guidelines August 2011

KILLS FOUR. Watch Informative Video

Patient presentation

MICROBIOLOGICAL TESTING IN PICU

GASTROENTERITIS. What you need to know BECAUSE...CARING COMES NATURALLY TO US

Is FMT the answer? Challenging Cases in CDI. Ted Steiner, M.D. April 1, 2016

Laboratory Investigation of. Infectious Diarrhoea. Quiz Feedback. bpac nz better medicine

Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017)

5/28/2015. Pregnancy, Birth and Postnatal for mother and baby. and Flu, oh my! An Update on Public Health Issues for Massage Therapists

True Pathogens of the Enterobacteriaceae: Salmonella, Shigella & Yersinia Salmonella

(3) Had a past illness from an infectious agent specified under paragraph (A)(1) of this rule; or:

severe diarrhea? Do you have ZINPLAVA is a medicine that helps reduce the risk that your C diff will come back.

MRSA The Facts. Staphylococcus aureus MRSA. Staphylococcus aureus, often referred to simply as "staph," What is Staphylococcus aureus?

Clostridium difficile Diagnostic and Clinical Challenges

GUIDELINE FOR THE MANAGEMENT OF ANTIBIOTIC- ASSOCIATED DIARRHOEA IN ADULTS

Injection Safety. Alana Cilwick, MPH. Injection Safety Coordinator

Staph Infection Fact Sheet

Transcription:

ECHO-Antibiotic Stewardship Program More Interesting Recent Literature Updates April 20, 2017 Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center

Antibiotic use earlier in life associated with increased risk for colorectal adenoma(cancer precursor) Long term use of antibiotics and risk of colorectal adenoma. Cao et al. Gut 2017- online first, April 4, 2017 1 16,000 women in long term Nurses Health Study 2 3 4 5 Studied any association of antibiotic use at age 20-39, 40-59 and more recent Assessed prospectively for subsequent development of colorectal adenomas Found women who used >2 months total of antibiotics during these early time periods had significantly increased risk. No association with recent use Likely related to change in gut flora leading to biological pathways that initiate or promote colorectal neoplasia

Hepatitis C Transmission from inappropriate Reuse of Saline Flush Syringes for multiple Patients in an Acute Care General Hospital MMWR 2017, 66(9) 258-60 RN noted to frequently leave a partially filled syringe near her desk. She admitted to reusing saline syringes for 6 months. Thought this was a safe, cost saving measure as no fluids were withdrawn into the syringe before injecting the flush. Admitted was never taught to do this She worked on telemetry ward where all patients had required iv access Hospital notified Health Dep't, 392 patients sent registered letters- offered free HIV, HCV and HBV testing. 67% tracked down. One patient with known HCV was on her ward. This HCV was matched genetically to another patient there at same time (rare genotype, identical sequence, no other association between the two patient). Hospitals should use this as a teaching lesson and the need for ongoing oversite of safe injection practices at their facilities Deja vu all over again

Speaking of the Devil Dipak Desai M.D. died last week at Renown Med Center Ran a GI clinic in Las Vegas, did sham 2 minute colonoscopies on 1000s of patients, reused sheets, contaminated syringes, single dose vials. City closed his office in 2008 Made $200,000,000 fortune Infected over 100 patients with Hepatitis C Found guilty of murder in 2013 Never lost his license 13 of his practice associates still licensed in NV

Notes from the Field: An Outbreak of Salmonella Typhimurium Associated with Playground Sand in a Preschool Setting Madrid, Spain, September October 2016 MMWR / March 10, 2017 / 66(9);256 257 Over a 6 week period, 24 kids (out of 300 children in a school) developed severe gastroenteritis. All stool cultures were positive for non-typhi Salmonella No evidence for any source at the school- facilities, food, potable water, personnel. No animals kept at the school. Because of ongoing epidemic- a common source exposure identified- the sand lot- surrounded by trees that birds roost in. Multiple samples from the lot grew the strain seen in the kids. Previously only reported in wild and domestic birds. Closing the sandlot ended the epidemic

Elimination of Screening Urine Cultures Prior to Elective Joint Arthroplasty Michael J. Lamb et al. Clin Infect Dis (2017) 64 (6): 806-809. Screening urine cultures are frequently done prior to joint arthroplasty despite no evidence of clinical benefit, and puts patient at risk for harmdrug reaction, C. difficle, resistance Toronto Orthopedic hospital did prospective study where they eliminated preoperative urine cultures and observed for 2 years. 1891 cases were done, 3 post-op wound infections all staph aureus. No urinary pathogens isolated. No role for pre- op cultures unless patient is symptomatic

Determination of clinical significance of coagulase-negative staph in blood cultures Karakullukcu,A et al Diag Micro and Inf Dis 2017,2914. Coag neg Staph (such as Staph epidermidis) are normal skin flora and thus common contaminants found in blood cultures. Usually dismissed as contaminants when only 1 /4 bottles are positive Often considered true positive if 2/4 bottles are positive and the organisms are identical for species and susceptibility pattern (phenotypic identification) Genotyping of these phenotypically identical staph, however often show unrelated genetic fingerprinting More useful to identify true infection- clinical criteria including time to positivity, presence of SIRS criteria, and a likely source of infection such as a central line. Using 1 vs 2 positive cultures to determine clinical significance was not in itself diagnostic of true infection.

Association of gastric acid suppression with recurrent CDI Tariq,R et al. JAMA Internal Medicine March 27,2017 Meta analysis from Mayo Clinic and UCSD Identified 7,700 patients with CDI. Approx 20% developed recurrent CDI. 22% of those on acid blockers relapsed versus 17% not on these meds. Rates stayed the same adjusted for age and cofounding factors The take away from this study and previous reports: Acid blockers are not only a risk for catching CDI, but also for increasing risk for relapse. Worth reviewing their prophylaxis indications at your facilities, and are they being arbitrarily continued after hospitalization

Clostridium difficle rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing Truong, C. et al Diagn Microbiol Infect Dis 2017 April:87(4);365-70 Study at Stanford Hospital looked at C. diff Toxin gene + PCR rates in asymptomatic patients versus patients with diarrhea. 11.8% of asymptomatic patients were PCR+. 15.4% of patients with diarrhea were PCR+. No significant difference in these rates. No difference in PCR cycles to reach threshold positive. Conclusion: asymptomatic C. diff carriage rate was similar to symptomatic rate suggests the majority of PCR + results in symptomatic patients are likely due to colonization. Disease-specific biomarkers are needed to accurately diagnose patients with C. diff Disease

Remember. C.diff colitis (CDI) is foremost a Clinical Diagnosis that is only then confirmed by lab tests. It is not simply a + lab test result Watery diarrhea (Bristol 7) is the cardinal symptom of C. difficile associated diarrhea (CDI) with colitis ( 3 loose stools in 24 hours). Other manifestations include lower abdominal pain and cramping, low-grade fever, nausea, anorexia, and leukocytosis

C. Diff Lab Diagnosis- remember it is the toxin that causes the symptoms Direct culture- not used - $$$/slow turn around time C. diff PCR- positive test only tells you C. difficile carrying the toxin B gene is present in the stool. 100% sensitive, but DOES NOT differentiate between those c.diff that are secreting the toxin and those that are not. Whether or not toxin is actually being secreted, the PCR test will be positive+ ELISA- Answers the question if the C. diff is actually producing toxin and causing disease? detects both the presence of C. difficile bacteria (GDH Ag) as well as detects toxin A +/- toxin B.

Lab comment given with C. diff PCR and Toxin results The clostridium difficile PCR test detects the toxin gene but not the actual presence of toxin. A positive PCR toxin test therefore does not differentiate between asymptomatic colonization and active disease. When the PCR test is positive, additional tests will be automatically performed which detect both C. difficile antigen (GDH) and the A and B toxin. These tests may be used in conjunction with the patient history as an aid in the diagnosis and treatment of C. difficile disease. Indeterminate results suggest testing be repeated on a fresh specimen